Piperazine citrate
枸缘酸哌嗪
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NamePiperazine citrate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1954/07/12
Country/Territory +[4]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesSichuan Emeishan Pharmaceutical Co Ltd
Inactive CompaniesBluline Ltd
Active Indications
Inactive IndicationsN/A